CNS Disorders  >>  staccato alprazolam (AZ-002)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
staccato alprazolam (AZ-002) / UCB
NCT00477451: Staccato Alprazolam in Panic Attack

Completed
2
49
US
Inhaled placebo, Inhaled alprazolam 1 mg, Inhaled alprazolam 2 mg, IV doxapram
Alexza Pharmaceuticals, Inc.
Treatment of Induced Panic Attack
04/08
04/08
NCT02351115: Staccato Alprazolam and Photoparoxysmal Response

Completed
2
5
US
A=Placebo, B=Inhaled Alprazolam 0.5 mg, C=Inhaled Alprazolam 1 m, D= Inhaled Alprazolam 2 mg, E=Placebo
Alexza Pharmaceuticals, Inc., The Epilepsy Study Consortium
Epilepsy
07/16
07/16
StATES, NCT03478982: Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Completed
2
156
US, RoW
Staccato Alprazolam, STAP-001, Placebos
Engage Therapeutics, Inc.
Epilepsy
12/19
01/20

Download Options